Hologic, Inc. (HOLX) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Marlborough, MA, United States. The current CEO is Stephen MacMillan.
HOLX has IPO date of 1990-03-01, 7,063 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $16.97B.
Hologic, Inc. is a global medical technology company that develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical solutions focused on women's health. Operating through four business segments—Diagnostics, Breast Health, GYN Surgical, and Skeletal Health—the company offers a comprehensive portfolio including molecular diagnostic assays for infectious disease detection, advanced breast imaging and biopsy systems, minimally invasive gynecological surgical devices, and orthopedic imaging solutions. Hologic serves healthcare providers across the United States, Europe, Asia-Pacific, and international markets through direct sales forces and independent distributors. Founded in 1985 and headquartered in Marlborough, Massachusetts, the company is committed to enabling early detection and treatment across the continuum of women's health.
